Reporting of potential immunogenicity with biologic drugs: clarity and accuracy required

Ann Rheum Dis. 2016 May;75(5):e24. doi: 10.1136/annrheumdis-2016-209178. Epub 2016 Feb 4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Neutralizing / blood*
  • Antirheumatic Agents / immunology*
  • Biological Products / immunology*
  • Biosimilar Pharmaceuticals
  • Etanercept / immunology*
  • Humans
  • Research Design

Substances

  • Antibodies, Neutralizing
  • Antirheumatic Agents
  • Biological Products
  • Biosimilar Pharmaceuticals
  • Etanercept